FDA Cheerios Warning Signals Tougher Stance On Health Claims Enforcement
This article was originally published in The Tan Sheet
Executive Summary
FDA's warning letter to General Mills concerning cardiovascular health claims linked to Cheerios reflects a newly empowered agency and foreshadows aggressive regulatory activity to come, experts say
You may also be interested in...
Claims Emerge To Join “Natural” As Class Action Fodder
Claims a product is “natural,” health and prevention claims, “whole grain” and “made with” claims, all can put a firm at risk for a lawsuit, the Center for Science in the Public Interest warns. After climbing for five years in a row, class action lawsuits brought against food products dipped in 2013, but the decline may be short-lived.
Claims Emerge To Join “Natural” As Class Action Fodder
Claims a product is “natural,” health and prevention claims, “whole grain” and “made with” claims, all can put a firm at risk for a lawsuit, the Center for Science in the Public Interest warns. After climbing for five years in a row, class action lawsuits brought against food products dipped in 2013, but the decline may be short-lived.
ConAgra’s Petition For Whole Grain/Diabetes Claim Draws Opposition
Kellogg Co. disagrees with ConAgra’s petition to FDA for a qualified health claim linking whole grain consumption with reduced risk of type 2 diabetes. Other experts question ConAgra’s supporting evidence and maintain fiber content should be emphasized over whole grains in product labeling.